Here's a look at some of the top legal news stories for medical device companies this week: Direct Flow Medical raises $32m, names 1st CCO; Medtronic prices $17B debt offering for Covidien buy; Conventus Orthopaedics raises $24m for arm fracture implants; Xeltis raises $34m for regenerative heart valve tech
Ally Bridge Group
, BioStar Ventures
, Blue Sky Fund
, Blue Stem Capital
, Conventus Orthopaedics
, Deerfield Management
, Direct Flow Medical Inc.
, Kurma Partners
, Life Sciences Partners
, PDL BioPharma
, Sightline Partners
, Spray Fund
, SV Life Sciences
, VI Partners
A federal appeals court vacates the $177 million in damages awarded to Covidien in its long-running patent infringement war with Johnson & Johnson's Ethicon End-Surgery unit over ultrasound shears technology.
UPDATED Dec. 4, 2014, with comment from Covidien and Johnson & Johnson.
Here's a look at some of the top Wall Street stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?; Medtronic expects to free up to $4B after IRS beef is settled; Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness; HCA hospitals halt use of uterine fibroid surgical tool
Chinese and South Korean regulators approve the planned $43 billion merger between medical device giants Medtronic and Covidien.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: FTC gives Medtronic, Covidien merger the green light; EU regulators clear Medtronic's Covidien buy; Medtronic prices $17B debt offering for Covidien buy
Medtronic says it priced $17 billion in a 7-tranche offering of senior notes worth a collective $17 billion, to help fund its $43 billion acquisition of Covidien.
Anti-trust regulators in Europe clear Medtronic's $43 billion acquisition of Covidien.